Wednesday, September 16, 2026Latest filing Sep 14, 2026

ASTH Congressional Stock Trades

Astrana Health Inc. - Common Stock (ASTH)

Last disclosed trade Aug 19

Every disclosed trade in ASTH by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Judy Chu · Sold $ASTH · Aug 19 · $100K–$250K

0.57MED
Disclosure speedx 0.250.60
Trade sizex 0.250.75
Cluster activityx 0.150.00
Track recordx 0.350.65

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $ASTH

Get notified when any member of Congress trades $ASTH. Free, no card, no spam.

Follow free →
2
Disclosed trades
1
Buys
1
Sells
1
Members trading

The record on $ASTH

Coldpine has parsed 2 disclosed trades in $ASTH by 1 member of Congress, drawn from 1 periodic transaction report dated Aug 19, 2025. All of them came from House members, all filed by Democrats.

Of the 2 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 11 days. The longest was 11 days: a $ASTH sale by Judy Chu dated Aug 19, 2025, disclosed Aug 30, 2025. How late filing is measured across all of Congress is in the late-filers study.

2 of the 2 trades that list an account holder (100%) were reported under a spouse, dependent child, or joint account rather than the member directly.

Members who trade ASTH

Recent disclosed trades in ASTH

DateMemberTypeAmount
Aug 19Judy Chu(CA)sell$100K–$250K
Aug 19Judy Chu(CA)buy$100K–$250K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →